Emerging technological innovations enabled by next-generation sensors will define the landscape for the future commercialization of life changing medical devices. The exponential growth of the global sensors market and the demand for next-generation integrated systems is expected to reach $18 billion by 2018. Low cost materials and advances in nano and micro fabrication techniques within the manufacturing process have led to significant increases in the commercialization of sensors for healthcare applications. Cambridge Healthtech Institute’s Biosensors conference, which will take place at the Aloft Boston Seaport Hotel, will examine the latest advancements in research and integration and will provide attendees with state-of-the-art sensors development for medical applications.
KEYNOTE PRESENTATION: Fluorescence Nanosensors for Continuous Glucose Monitoring
Kaiming Ye, Professor and Department Chair, SUNY,